Jerome Ritz Selected Research

Jerome Ritz Research Topics

Disease

54	Neoplasms (Cancer) 01/2022 - 05/2002
47	Bronchiolitis Obliterans Syndrome 11/2022 - 04/2004
33	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2022 - 09/2002
29	Leukemia 12/2022 - 06/2002
20	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 10/2003
12	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 10/2006
11	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2014 - 05/2002
10	Multiple Myeloma 12/2020 - 06/2002
9	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2022 - 10/2006
8	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 12/2005
5	Disease Progression 01/2021 - 03/2011
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 06/2005
4	Lymphoma (Lymphomas) 01/2022 - 12/2016
4	Infections 01/2022 - 04/2012
4	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020 - 04/2004
4	Melanoma (Melanoma, Malignant) 01/2018 - 05/2002
3	Bronchiolitis Obliterans 12/2022 - 02/2012
3	Viremia 01/2022 - 05/2010
3	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 05/2017
3	Virus Diseases (Viral Diseases) 01/2021 - 01/2020
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020 - 06/2002
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019 - 01/2016
2	Injection Site Reaction 12/2022 - 11/2017
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2020
2	Anemia 11/2021 - 01/2021
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2016
2	COVID-19 01/2021 - 07/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 05/2002
2	Fibrosis (Cirrhosis) 01/2017 - 02/2012
2	Myeloid Leukemia (Leukemia, Myelocytic) 03/2015 - 02/2010
2	Renal Cell Carcinoma (Grawitz Tumor) 02/2009 - 08/2008
2	Blast Crisis (Blast Phase) 08/2004 - 12/2002
1	Immune System Diseases (Immune Disorders) 01/2022
1	Chronic Renal Insufficiency 01/2021

Drug/Important Bio-Agent (IBA)

20	AntigensIBA 01/2021 - 05/2002
15	Interleukin-2 (IL2)IBA 11/2022 - 02/2002
12	VaccinesIBA 12/2022 - 05/2002
11	AntibodiesIBA 01/2018 - 05/2002
10	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2004
8	Tacrolimus (Prograf)FDA LinkGeneric 12/2022 - 10/2009
8	Minor Histocompatibility AntigensIBA 03/2010 - 01/2003
7	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2022 - 05/2002
6	Methotrexate (Mexate)FDA LinkGeneric 12/2022 - 10/2009
6	SteroidsIBA 11/2022 - 08/2004
5	CytokinesIBA 01/2022 - 02/2002
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2013
5	Bortezomib (Velcade)FDA Link 01/2018 - 10/2009
5	Peptides (Polypeptides)IBA 01/2017 - 01/2004
5	Complementary DNA (cDNA)IBA 03/2015 - 05/2002
4	Sirolimus (Rapamycin)FDA Link 01/2020 - 01/2018
4	Biological ProductsIBA 11/2017 - 06/2005
4	Immunoglobulins (Immunoglobulin)IBA 06/2014 - 02/2010
4	Rituximab (Mabthera)FDA Link 06/2013 - 06/2002
3	Cell-Free Nucleic AcidsIBA 01/2022 - 07/2020
3	InterferonsIBA 12/2020 - 06/2015
3	Pharmaceutical PreparationsIBA 12/2020 - 11/2016
3	LigandsIBA 01/2020 - 06/2015
3	EpitopesIBA 01/2019 - 01/2004
3	Immune Checkpoint InhibitorsIBA 01/2018 - 07/2016
3	Monoclonal AntibodiesIBA 01/2017 - 10/2002
3	Interferon-gamma (Interferon, gamma)IBA 06/2015 - 02/2002
3	B-Cell Activating FactorIBA 05/2014 - 10/2007
2	pembrolizumabIBA 01/2022 - 01/2019
2	Interleukin-22 (IL-22)IBA 11/2021 - 01/2021
2	IpilimumabIBA 10/2021 - 07/2016
2	Chimeric Antigen ReceptorsIBA 01/2020 - 01/2018
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 12/2017
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2019
2	Thomsen-Friedenreich antibodiesIBA 11/2018 - 12/2017
2	GlobulinsIBA 11/2018 - 12/2017
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2018 - 05/2010
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 02/2012
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018 - 07/2006
2	Programmed Cell Death 1 ReceptorIBA 01/2018 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 05/2010
2	Busulfan (Busulfex)FDA Link 11/2015 - 06/2010
2	fludarabineIBA 11/2015 - 06/2010
2	Interleukin-2 Receptors (IL 2 Receptor)IBA 10/2014 - 11/2009
2	Alemtuzumab (Campath)FDA Link 06/2013 - 05/2013
2	Nucleic AcidsIBA 04/2011 - 02/2009
2	Staphylococcal Protein A (Protein A)IBA 02/2009 - 01/2008
2	OligonucleotidesIBA 05/2007 - 01/2006
2	AutoantibodiesIBA 03/2007 - 10/2002
2	Imatinib Mesylate (Gleevec)FDA Link 08/2004 - 01/2004
1	ChromatinIBA 12/2022
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 12/2022
1	CalcineurinIBA 10/2022
1	RNA (Ribonucleic Acid)IBA 01/2022

Therapy/Procedure

57	Hematopoietic Stem Cell Transplantation 11/2022 - 10/2002
37	Therapeutics 01/2022 - 02/2002
21	Transplantation 10/2021 - 06/2002
17	Stem Cell Transplantation 01/2022 - 09/2002
13	Cell Transplantation 10/2022 - 10/2006
11	Immunotherapy 01/2022 - 06/2002
6	Drug Therapy (Chemotherapy) 01/2022 - 10/2006
5	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2016 - 07/2002
4	Homologous Transplantation 11/2020 - 08/2004
2	Aftercare (After-Treatment) 11/2021 - 02/2010
2	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2021 - 01/2018
1	Duration of Therapy 01/2021